Table 2.
Selected mesenchymal intracellular signaling pathways involved in pancreas development
Signaling pathway | SOA in pancreatic mesenchyme | SOA* in pancreatic epithelium | Function (in pancreas) | LOF (in pancreas) | Referencess |
---|---|---|---|---|---|
BMP | E9.5-E12.5 | ND |
• Normal development of mesenchyme • Regulation of cellular composition |
• Production of endocrines concomitant to exocrine decrease • Severe hypoplasia • Reduced epithelial branching • Anterior extension of dorsal pancreas into stomach mesenchyme • Vascular remodeling |
[217] |
RA | ~ E11 | E11 |
• Exocrine lineage selection • Up-regulation of mesenchymal laminin-1 • Ductal differentiation • Generation of Ngn3+ and β-cells |
• Production of acinar cells in favor of ductal cells | [218–220] |
Wnt | ~ E13 | E13.5 |
• Expansion/differentiation of epithelial progenitors • Regulation of organ growth • Survival/expansion of mesenchyme |
• Reduced PP proliferation and hypoplasia • Decrease in endocrine progenitor and islet cell mass • Reduced β-, PP-, and delta- cells but not alpha-cells |
[221, 222] |
SHH | ≥ E13 | ≤ 2nd transition |
• Regulation of alpha and β-cell growth rate • Fine-tuning for proper development/organogenesis |
• Severe agenesis in onset of development# • Reduced endocrine and exocrine area • Disrupted islet morphology and cellular composition at E14.5# |
[223–227] |
LOF results of loss of function, SOA stage of activation, ND no data provided
*This table displays the signaling pathways activated intracellularly in the mesenchyme compartment while this column shows the time of activation of these signaling pathways in the epithelium compartment
#While this column displays the effects of LOF of SHH, these items are caused by its gain of function!